Zhang Xiang-Fu, Huang Chang-Ming, Lu Hui-Shan, Wu Xing-Yuan, Wang Chuang, Guang Guo-Xian, Zhang Jian-Zhong, Zheng Chao-Hui
Department of Oncology, Affiliated Union Hospital of Fujian Medical University, Fuzhou 350001, Fujian Province, China.
World J Gastroenterol. 2004 Dec 1;10(23):3405-8. doi: 10.3748/wjg.v10.i23.3405.
To analyze the factors influencing the prognosis of patients with gastric cancer after surgical treatment, in order to optimize the surgical procedures.
A retrospective study of 2 613 consecutive patients with gastric cancer was performed. Of these patients, 2,301 (88.1%) received operations; 196 explorative laparotomy (EL), 130 by-pass procedure (BPP), and 1 975 surgical resection of the tumors (891 palliative resection and 1 084 curative resection). The survival rate was calculated by the actuarial life table method, and the prognostic factors were evaluated using the Cox regression proportional hazard model.
Of the patients, 2,450 (93.8%) were followed-up. The median survival period was 4.6 mo for patients without operation, 5.2 mo for EL, 6.4 mo for BPP, and 15.2 mo for palliative resection (P = 0.0001). Of the patients with surgical resection of the tumors, the overall 1, 3 and 5-year survival rates after were 82.7%, 46.3% and 31.1%, respectively, with the 5-year survival rate being 51.2% in patients with curative resection, and 7.8% for those with palliative resection. The 5-year survival rate was 32.5% for patients with total gastrectomy, and 28.3% for those with total gastrectomy plus resection of the adjacent organs. The factors that independently correlated with poor survival included advanced stage, upper third location, palliative resection, poor differentiation, type IV of Borrmann classification, tumor metastasis (N3), tumor invasion into the serosa and contiguous structure, proximal subtotal gastrectomy for upper third carcinoma and D1 lymphadenectomy after curative treatment.
The primary lesion should be resected as long as the local condition permitted for stage III and IV tumors, in order to prolong the patients' survival and improve their quality of life after operation. Total gastrectomy is indicated for carcinomas in the cardia and fundus, and gastric cancer involving the adjacent organs without distant metastasis requires gastrectomy with resection of the involved organs.
分析影响胃癌患者手术治疗后预后的因素,以优化手术方案。
对2613例连续性胃癌患者进行回顾性研究。其中,2301例(88.1%)接受了手术;196例行剖腹探查术(EL),130例行旁路手术(BPP),1975例行肿瘤手术切除(891例姑息性切除,1084例根治性切除)。采用寿命表法计算生存率,应用Cox回归比例风险模型评估预后因素。
2450例(93.8%)患者获得随访。未手术患者的中位生存期为4.6个月,EL患者为5.2个月,BPP患者为6.4个月,姑息性切除患者为15.2个月(P = 0.0001)。在接受肿瘤手术切除的患者中,术后1、3和5年总生存率分别为82.7%、46.3%和31.1%,根治性切除患者的5年生存率为51.2%,姑息性切除患者为7.8%。全胃切除患者的5年生存率为32.5%,全胃切除加邻近器官切除患者为28.3%。与生存不良独立相关的因素包括晚期、上1/3部位、姑息性切除、低分化、Borrmann分类IV型、肿瘤转移(N3)、肿瘤侵犯浆膜和邻近结构、上1/3癌近端胃大部切除术以及根治性治疗后D1淋巴结清扫术。
对于Ⅲ期和Ⅳ期肿瘤,只要局部条件允许,应切除原发病灶,以延长患者生存期并提高术后生活质量。贲门和胃底癌应行全胃切除术,累及邻近器官且无远处转移的胃癌需要行胃切除术并切除受累器官。